12.07.2015 Views

Women with Disabilities: Barriers and Facilitators to Accessing ...

Women with Disabilities: Barriers and Facilitators to Accessing ...

Women with Disabilities: Barriers and Facilitators to Accessing ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

WOMEN WITH DISABILITIES: BARRIERS AND FACILITATORS TO ACCESSING SERVICES DURING PREGNANCY,CHILDBIRTH AND EARLY MOTHERHOODSchool of Nursing <strong>and</strong> Midwifery, Trinity College Dublinwomen the risks associated <strong>with</strong> becoming pregnant while on medication <strong>and</strong>the risk associated <strong>with</strong> s<strong>to</strong>pping medication abruptly or in a controlled manner.Despite this the evidence suggests that women are not informed about theirmedications <strong>and</strong> often struggle alone <strong>with</strong> the dilemma of s<strong>to</strong>pping medication<strong>and</strong> risking their own mental health, or continuing the medication <strong>and</strong> worryingabout exposing the fetus or baby <strong>to</strong> harmful effects (Thomas, 1997; Chernomaset al, 2000). Einearson et al (2001), in their Canadian study, found that of the 36women involved, 34 (94%) had discontinued psychiatric medication abruptly forfear of birth defects <strong>and</strong> harming their baby. As a consequence, many of thewomen suffered both physical <strong>and</strong> psychological adverse effects, includingsuicidal thoughts. In the majority of cases the women s<strong>to</strong>pped their medicationon the advice of a doc<strong>to</strong>r (family physician or psychiatrist), who in their haste <strong>to</strong>ensure a ‘drug free pregnancy’ may not have considered fully theconsequences of their actions. Conflict over taking anti-depressant medication<strong>and</strong> breast-feeding was also an issue for women, postnatally. <strong>Women</strong> reportedfearing transmitting the medication <strong>to</strong> the baby during breast-feeding or fearingthat medication would disrupt the breast-feeding experience (Ugarriza, 2002).Consequently, some of the women in Ugarriza’s (2002:pg. 232) study s<strong>to</strong>ppedtaking medication because they did not want <strong>to</strong> ‘fail’ at breast-feeding,perceiving themselves <strong>to</strong> have already failed the test for being a ‘good mother’.5.9.3. Fears of impaired ability <strong>to</strong> care for their children<strong>Women</strong> also expressed concern about having <strong>to</strong> be maintained on medication<strong>to</strong> prevent relapse. The women in Montgomery et al’s (2006) study spoke of themedication as simply ‘masking’ symp<strong>to</strong>ms, <strong>with</strong>out having any appreciableeffect on their ‘suffering’. <strong>Women</strong> in 2 other studies (Chernomas et al, 2000;Diaz-Canjela <strong>and</strong> Johnson, 2004) described how the medication slowed themdown, reduced their concentration <strong>and</strong> impaired their ability <strong>to</strong> look after theirchildren. Fatigue also prevented them from attending <strong>to</strong> their own appearance<strong>and</strong> personal grooming. Consequently, some women made decisions <strong>to</strong> forgomedication that was slowing them down so that they could parent <strong>and</strong>breastfeed (Nicholson et al, 1998c; Brunette <strong>and</strong> Dean, 2002). Althoughmedication may be necessary in the acute phase of illness, the over-reliance on108

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!